| 
39
 | 
     1 <html>
 | 
| 
 | 
     2 
 | 
| 
 | 
     3 <head>
 | 
| 
 | 
     4 <meta http-equiv=Content-Type content="text/html; charset=windows-1252">
 | 
| 
 | 
     5 <meta name=Generator content="Microsoft Word 14 (filtered)">
 | 
| 
 | 
     6 <style>
 | 
| 
 | 
     7 <!--
 | 
| 
 | 
     8  /* Font Definitions */
 | 
| 
 | 
     9  @font-face
 | 
| 
 | 
    10 	{font-family:Calibri;
 | 
| 
 | 
    11 	panose-1:2 15 5 2 2 2 4 3 2 4;}
 | 
| 
 | 
    12 @font-face
 | 
| 
 | 
    13 	{font-family:UICTFontTextStyleBody;}
 | 
| 
 | 
    14  /* Style Definitions */
 | 
| 
 | 
    15  p.MsoNormal, li.MsoNormal, div.MsoNormal
 | 
| 
 | 
    16 	{margin-top:0in;
 | 
| 
 | 
    17 	margin-right:0in;
 | 
| 
 | 
    18 	margin-bottom:10.0pt;
 | 
| 
 | 
    19 	margin-left:0in;
 | 
| 
 | 
    20 	line-height:115%;
 | 
| 
 | 
    21 	font-size:11.0pt;
 | 
| 
 | 
    22 	font-family:"Calibri","sans-serif";}
 | 
| 
 | 
    23 a:link, span.MsoHyperlink
 | 
| 
 | 
    24 	{color:blue;
 | 
| 
 | 
    25 	text-decoration:underline;}
 | 
| 
 | 
    26 a:visited, span.MsoHyperlinkFollowed
 | 
| 
 | 
    27 	{color:purple;
 | 
| 
 | 
    28 	text-decoration:underline;}
 | 
| 
 | 
    29 span.apple-converted-space
 | 
| 
 | 
    30 	{mso-style-name:apple-converted-space;}
 | 
| 
 | 
    31 .MsoChpDefault
 | 
| 
 | 
    32 	{font-family:"Calibri","sans-serif";}
 | 
| 
 | 
    33 .MsoPapDefault
 | 
| 
 | 
    34 	{margin-bottom:10.0pt;
 | 
| 
 | 
    35 	line-height:115%;}
 | 
| 
 | 
    36 @page WordSection1
 | 
| 
 | 
    37 	{size:8.5in 11.0in;
 | 
| 
 | 
    38 	margin:1.0in 1.0in 1.0in 1.0in;}
 | 
| 
 | 
    39 div.WordSection1
 | 
| 
 | 
    40 	{page:WordSection1;}
 | 
| 
 | 
    41 -->
 | 
| 
 | 
    42 </style>
 | 
| 
 | 
    43 
 | 
| 
 | 
    44 </head>
 | 
| 
 | 
    45 
 | 
| 
 | 
    46 <body lang=EN-US link=blue vlink=purple>
 | 
| 
 | 
    47 
 | 
| 
 | 
    48 <div class=WordSection1>
 | 
| 
 | 
    49 
 | 
| 
 | 
    50 <p class=MsoNormalCxSpFirst style='text-align:justify'><b><span lang=EN-GB
 | 
| 
 | 
    51 style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>References</span></b></p>
 | 
| 
 | 
    52 
 | 
| 
 | 
    53 <p class=MsoNormalCxSpMiddle style='text-align:justify'><span lang=EN-GB
 | 
| 
 | 
    54 style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif";
 | 
| 
 | 
    55 color:black'>Yaari, G. and Uduman, M. and Kleinstein, S. H. (2012). Quantifying
 | 
| 
 | 
    56 selection in high-throughput Immunoglobulin sequencing data sets. In<span
 | 
| 
 | 
    57 class=apple-converted-space> </span><em>Nucleic Acids Research, 40 (17),
 | 
| 
 | 
    58 pp. e134–e134.</em><span class=apple-converted-space><i> </i></span>[</span><span
 | 
| 
 | 
    59 lang=EN-GB><a href="http://dx.doi.org/10.1093/nar/gks457" target="_blank"><span
 | 
| 
 | 
    60 style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif";
 | 
| 
 | 
    61 color:#303030'>doi:10.1093/nar/gks457</span></a></span><span lang=EN-GB
 | 
| 
 | 
    62 style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif";
 | 
| 
 | 
    63 color:black'>][</span><span lang=EN-GB><a
 | 
| 
 | 
    64 href="http://dx.doi.org/10.1093/nar/gks457" target="_blank"><span
 | 
| 
 | 
    65 style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif";
 | 
| 
 | 
    66 color:#303030'>Link</span></a></span><span lang=EN-GB style='font-size:12.0pt;
 | 
| 
 | 
    67 line-height:115%;font-family:"Times New Roman","serif";color:black'>]</span></p>
 | 
| 
 | 
    68 
 | 
| 
 | 
    69 <p class=MsoNormalCxSpMiddle style='text-align:justify'><b><span lang=EN-GB
 | 
| 
 | 
    70 style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>Graphs</span></b></p>
 | 
| 
 | 
    71 
 | 
| 
 | 
    72 <p class=MsoNormalCxSpMiddle style='text-align:justify'><u><span lang=EN-GB
 | 
| 
 | 
    73 style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>AA
 | 
| 
 | 
    74 mutation frequency</span></u></p>
 | 
| 
 | 
    75 
 | 
| 
 | 
    76 <p class=MsoNormalCxSpMiddle style='text-align:justify'><span lang=EN-GB
 | 
| 
 | 
    77 style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>For
 | 
| 
 | 
    78 each class, the frequency of replacement mutations at each amino acid position
 | 
| 
 | 
    79 is shown, which is calculated by dividing the number of replacement mutations
 | 
| 
 | 
    80 at a particular amino acid position/the number sequences that have an amino
 | 
| 
 | 
    81 acid at that particular position. Since the length of the CDR1 and CDR2 region
 | 
| 
 | 
    82 is not the same for every VH gene, some amino acids positions are absent.
 | 
| 
 | 
    83 Therefore we calculate the frequency using the number of amino acids present at
 | 
| 
 | 
    84 that that particular location. </span></p>
 | 
| 
 | 
    85 
 | 
| 
 | 
    86 <p class=MsoNormalCxSpMiddle style='text-align:justify'><u><span lang=EN-GB
 | 
| 
 | 
    87 style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>Antigen
 | 
| 
 | 
    88 selection (BASELINe)</span></u></p>
 | 
| 
 | 
    89 
 | 
| 
 | 
    90 <p class=MsoNormalCxSpMiddle style='text-align:justify'><span lang=EN-GB
 | 
| 
 | 
    91 style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>Shows
 | 
| 
 | 
    92 the results of the analysis of antigen selection as performed using BASELINe.
 | 
| 
 | 
    93 Details on the analysis performed by BASELINe can be found in Yaari et al,
 | 
| 
 | 
    94 PMID: 22641856. The settings used for the analysis are</span><span lang=EN-GB
 | 
| 
 | 
    95 style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>:
 | 
| 
 | 
    96 focused, SHM targeting model: human Tri-nucleotide, custom bounderies. The
 | 
| 
 | 
    97 custom boundries are dependent on the ‘sequence starts at filter’. </span></p>
 | 
| 
 | 
    98 
 | 
| 
 | 
    99 <p class=MsoNormalCxSpMiddle style='line-height:normal'><span lang=NL
 | 
| 
 | 
   100 style='font-family:UICTFontTextStyleBody;color:black'>Leader:
 | 
| 
 | 
   101 1:26:38:55:65:104:-</span></p>
 | 
| 
 | 
   102 
 | 
| 
 | 
   103 <p class=MsoNormalCxSpMiddle style='line-height:normal'><span lang=NL
 | 
| 
 | 
   104 style='font-family:UICTFontTextStyleBody;color:black'>FR1: 27:27:38:55:65:104:-</span></p>
 | 
| 
 | 
   105 
 | 
| 
 | 
   106 <p class=MsoNormalCxSpMiddle style='line-height:normal'><span lang=NL
 | 
| 
 | 
   107 style='font-family:UICTFontTextStyleBody;color:black'>CDR1: 27:27:38:55:65:104:-</span></p>
 | 
| 
 | 
   108 
 | 
| 
 | 
   109 <p class=MsoNormalCxSpLast style='line-height:normal'><span lang=NL
 | 
| 
 | 
   110 style='font-family:UICTFontTextStyleBody;color:black'>FR2: 27:27:38:55:65:104:-</span></p>
 | 
| 
 | 
   111 
 | 
| 
 | 
   112 <p class=MsoNormal><span lang=NL style='font-size:12.0pt;line-height:115%;
 | 
| 
 | 
   113 font-family:"Times New Roman","serif"'>Hanna IJspeert, Pauline A. van
 | 
| 
 | 
   114 Schouwenburg, David van Zessen, Ingrid Pico-Knijnenburg, Gertjan J. Driessen,
 | 
| 
 | 
   115 Andrew P. Stubbs, and Mirjam van der Burg (2016). </span><span
 | 
| 
 | 
   116 style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>Evaluation
 | 
| 
 | 
   117 of the Antigen-Experienced B-Cell Receptor Repertoire in Healthy Children and
 | 
| 
 | 
   118 Adults. In <i>Frontiers in Immunolog, 7, pp. e410-410. </i>[<a
 | 
| 
 | 
   119 href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5066086/"><span
 | 
| 
 | 
   120 style='color:windowtext'>doi:10.3389/fimmu.2016.00410</span></a>][<a
 | 
| 
 | 
   121 href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5066086/"><span
 | 
| 
 | 
   122 style='color:windowtext'>Link</span></a>]</span></p>
 | 
| 
 | 
   123 
 | 
| 
 | 
   124 </div>
 | 
| 
 | 
   125 
 | 
| 
 | 
   126 </body>
 | 
| 
 | 
   127 
 | 
| 
 | 
   128 </html>
 |